Specialty Pharmacy

The day-to-day struggle of a mom dealing with the symptoms of multiple sclerosis.

Keytruda showed an improvement in overall survival compared with chemotherapy in patients with NSCLC.

Announcement increases access for Praluent to formularies that cover in excess of 170 million lives across the United States.

Drug that treats GNE myopathy (GNEM) causes improved muscle strength in upper extremities.

New colorectal cancer screening guidelines call for biweekly screenings for adults aged 50 to 74 years for colorectal cancer with FOBT or flexible sigmoidoscopy every 10 years.

New method examines the genetic background of tumors for more effective prostate cancer therapy.

Consolidated administrative services organization with national reach seeks to help independent pharmacies with managed care contracts and Star Ratings.

Researchers compare prescription refill records among patients who refill medications via mail order and traditional pharmacy.

Caregivers should closely monitor hepatitis C infection in patients undergoing chemotherapy.

New once-daily formulation of Isentress shows similar efficacy to the currently approved twice-daily formulation of the HIV treatment.

Treatment shows promise in fighting lymphoma in early studies.

Phenytoin may help reduce the symptoms of multiple sclerosis.

Pharmacist-led interventions support optimal medication safety outcomes.

New analysis provides faster tests and lower costs for women with estrogen positive-receptor (ER-positive) breast cancer.

Discovery may lead to significant new HIV treatments.

Recent advances and updates in oncology and cancer drug development.

ONC201 caused p53-independent cell death and cell cycle arrest in lymphoma and acute leukemia patient samples.

Despite progress in legalizing medical marijuana, incorporating it into clinical trials for epilepsy to prevent seizures remains difficult.

Catch up with the latest developments across the health care landscape and sign up for key upcoming conferences.

Ibrutinib (Imbruvica) is the first chemotherapy-free treatment for first line CLL patients approved by the FDA.

Study found no standalone Medicare Part D plans covered vaccinations without out-of-pocket payments.

The latest Magellan Health report highlights spending trends and current pharmacy benefit issues.

Dan Steiber, Editor in Chief for Specialty Pharmacy Times, discusses limited distribution and other pressing issues impacting the specialty pharmacy landscape in a recent podcast.

Abraxane treats patients with advanced, squamous non-small cell lung cancer (NSCLC).

Ocrelizumab shows promise reducing symptoms of MS.

Ocrelizumab selectively targets CD20+B cells to reduce disease activity in patients with primary progressive multiple sclerosis.

Most read articles of the week on Specialty Pharmacy Times.

Nearly half of patients required 10 or more office visits before receiving a Crohn's disease diagnosis.